Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government
The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July. While Serum Institute is to supply 11 crore doses of Covishield, the rest will be Covaxin manufactured by Bharat Biotech. Based on the advance paid on April 28, the price works out to a little under Rs 160 per shot.
💡 newsR Knowledge: Other News Mentions
Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programmeBharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 yearsNot just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in India
PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News
Credit: Oneindia Duration: 02:22Published
No application received from SII for EU authorisation of Covishield vaccine: EMAPoonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter.
Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News
Credit: Oneindia Duration: 02:37Published
India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia
Credit: Oneindia Duration: 02:02Published
SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News
Credit: Oneindia Duration: 01:31Published
Hear doctor's emotional plea for people to get vaccinated
Credit: Bleacher Report AOL Duration: 03:37Published
On GPS: Covid's Delta variant wreaks havoc
Credit: Bleacher Report AOL Duration: 04:26Published
On GPS: What to make of Covid "Breakthrough infections"
Credit: Bleacher Report AOL Duration: 06:26Published
Stelter: News coverage should help you assess Covid-19 risk
Credit: Bleacher Report AOL Duration: 02:11Published
COVID-19 vaccine for children likely by September: AIIMS ChiefIn view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
French Government allows Covishield-jabbed travellers into the country | AstraZeneca | Oneindia News
Credit: Oneindia Duration: 01:39Published
France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countriesThe European Union only recognises AstraZeneca manufactured vaccines as a certificate for COVID-19 travel
You Might Like
Related videos from verified sources
Related news from verified sources